Jump to main content
Jump to site search


Hyperbranched polyglycerols: recent advances in synthesis, biocompatibility and biomedical applications

Author affiliations

Abstract

In the pursuit of dendrimer alternatives, hyperbranched polymers have found increasing interest from academia and industry in a broad range of fields due to their topological and synthetic advantages. Hyperbranched polyglycerol (HPG), as the name implies, is a hyperbranched polymer with about 50–65% dendrimeric structure. Due to its ease in synthesis, globular nature, versatility in terms of functionalization, and superb biocompatibility profiles HPG provides a promising class of materials suitable for numerous applications in nanomedicine and biomedical technologies. The structural features of HPG can be easily tailored by adopting different synthetic methodologies. In this review, we briefly explore the synthesis of HPGs starting from the traditional Lewis acid based approaches to recent advances including the development of high MW HPGs, biodegradable HPGs, co-block HPGs and sustainable or ‘green’ HPG synthesis. The robust history of HPG biocompatibility is extensively reviewed giving examples of both in vitro and in vivo models. In particular, HPG showed very minimal polymer accumulation in vital organs after intravenous injection compared to other polymers widely used for various biomedical applications. HPG is well tolerated in mice and rats, and has been found to be non-immunogenic to date. Due to its demonstrated safety profile and multifunctionality, HPG has been extensively studied for different biomedical applications including as macromolecular therapeutics, multivalent inhibitors/scavengers, in controlled drug delivery systems, in organ preservation, dialysis and cell surface engineering, as imaging agents and theranostics, in the development of anti-fouling surfaces and proteomics reagents. We highlight these applications along with its advantages. Finally, we conclude by providing a future prospective of HPG as one of the promising PEG alternatives with a great potential to enter clinical trials in the near future.

Graphical abstract: Hyperbranched polyglycerols: recent advances in synthesis, biocompatibility and biomedical applications

Back to tab navigation

Publication details

The article was received on 20 Sep 2017, accepted on 30 Oct 2017 and first published on 07 Nov 2017


Article type: Review Article
DOI: 10.1039/C7TB02515G
Citation: J. Mater. Chem. B, 2017, Advance Article
  •   Request permissions

    Hyperbranched polyglycerols: recent advances in synthesis, biocompatibility and biomedical applications

    S. Abbina, S. Vappala, P. Kumar, E. M. J. Siren, C. C. La, U. Abbasi, D. E. Brooks and J. N. Kizhakkedathu, J. Mater. Chem. B, 2017, Advance Article , DOI: 10.1039/C7TB02515G

Search articles by author

Spotlight

Advertisements